Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5825786 | Clinical Therapeutics | 2012 | 9 Pages |
Abstract
Third-party reclassification may be possible in some countries, particularly where supply can be limited to pharmacists only. A flexible approach may be needed from the committee and regulator to assist such reclassification. Given the multiple beneficiaries of reclassification, removing reliance on the pharmaceutical companies to drive reclassification and/or using new models of supply may provide impetus to the reclassification arena.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Natalie MPharm, Lynne BPharm(Hons), PhD, Fiona PhD, Stephen PhD,